ePrints

The HALO study: A phase I-II of the oral HSP90 inhibitor Debio0932 in combination with SOC in first- and second-line therapy of advanced NSCLC

Lookup NU author(s): Professor Ruth Plummer

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Jaime JC, Paz-Ares L, Provencio M, Bennouna J, Ponce-Aix S, Plummer R, Delord JP, Isambert N, Trigo JM, Belli R, Brienza S, Zanna C, Purcea D, Calvo V, Alonso M, Senellart H, Hiret S, Marti AM, Felip E

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 2014 Annual Meeting of the American Society of Clinical Oncology

Year of Conference: 2014

Pages: TPS2632

Print publication date: 20/05/2014

Acceptance date: 01/01/1900

ISSN: 0732-183X

Publisher: American Society of Clinical Oncology

URL: https://doi.org/10.1200/jco.2014.32.15_suppl.tps2632

DOI: 10.1200/jco.2014.32.15_suppl.tps2632

Series Title: Journal of Clinical Oncology

Share